Archives of cardiovascular diseases, 2017, 110 (2), pp.69-71. ⟨10.1016/j.acvd.2016.12.004⟩
Charles Guenancia, Sylvain Ladoire, François Ghiringelli, Luc Rochette, Catherine Vergely, et al.. Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer. Archives of cardiovascular diseases, 2017, 110 (2), pp.69-71. ⟨10.1016/j.acvd.2016.12.004⟩ (lien externe). ⟨hal-03433298⟩ (lien externe)
Citations
APA
Guenancia, C., Ladoire, S., Ghiringelli, F., Rochette, L., Vergely, C., & Cottin, Y. (2017). Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer. In Archives of cardiovascular diseases. https://doi.org/10.1016/j.acvd.2016.12.004
MLA
Guenancia, Charles, et al. “Implications of Excess Weight in the Cardiotoxicity of Anthracyclines and Trastuzumab in Breast Cancer.” Archives of Cardiovascular Diseases, Feb. 2017, https://doi.org/10.1016/j.acvd.2016.12.004.
Chicago
Guenancia, Charles, Sylvain Ladoire, François Ghiringelli, Luc Rochette, Catherine Vergely, and Yves Cottin. 2017. “Implications of Excess Weight in the Cardiotoxicity of Anthracyclines and Trastuzumab in Breast Cancer.” Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2016.12.004.
Harvard
Guenancia, C. et al. (2017) “Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer,” Archives of cardiovascular diseases. Available at: https://doi.org/10.1016/j.acvd.2016.12.004.
ISO 690
GUENANCIA, Charles, LADOIRE, Sylvain, GHIRINGELLI, François, ROCHETTE, Luc, VERGELY, Catherine and COTTIN, Yves, 2017. Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer [en ligne]. February 2017. Disponible à l'adresse : https://doi.org/10.1016/j.acvd.2016.12.004